loadpatents
name:-0.017738103866577
name:-0.016377925872803
name:-0.00059914588928223
DUBE; Daniel Patent Filings

DUBE; Daniel

Patent Applications and Registrations

Patent applications and USPTO patent grants for DUBE; Daniel.The latest application filed is for "libraries of heteroaryl-containing macrocyclic compounds and methods of making and using the same".

Company Profile
0.26.32
  • DUBE; Daniel - Saint-Lazare CA
  • Dube; Daniel - St. Lazare CA
  • Dube; Daniel - Saint-Lazare-de-Vaudreuil CA
  • Dube; Daniel - Saint-Lazaire CA
  • Dube; Daniel - Kirkland CA
  • Dube; Daniel - Quebec CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Libraries Of Heteroaryl-containing Macrocyclic Compounds And Methods Of Making And Using The Same
App 20210284655 - WAHHAB; Amal ;   et al.
2021-09-16
Libraries of heteroaryl-containing macrocyclic compounds and methods of making and using the same
Grant 10,981,931 - Wahhab , et al. April 20, 2
2021-04-20
Libraries Of Pyridine-containing Macrocyclic Compounds And Methods Of Making And Using The Same
App 20200190083 - WAHHAB; Amal ;   et al.
2020-06-18
Libraries Of Heteroaryl-containing Macrocyclic Compounds And Methods Of Making And Using The Same
App 20200157116 - WAHHAB; Amal ;   et al.
2020-05-21
Libraries of heteroaryl-containing macrocyclic compounds and methods of making and using the same
Grant 10,407,442 - Wahhab , et al. Sept
2019-09-10
Libraries Of Diverse Macrocyclic Compounds And Methods Of Making And Using The Same
App 20190153620 - MACDONALD; Dwight ;   et al.
2019-05-23
Libraries Of Heteroaryl-containing Macrocyclic Compounds And Methods Of Making And Using The Same
App 20180265521 - WAHHAB; Amal ;   et al.
2018-09-20
3,4-substituted piperidine derivatives as renin inhibitors
Grant 8,889,714 - Chen , et al. November 18, 2
2014-11-18
Case of renin inhibitors
Grant 8,343,968 - Wu , et al. January 1, 2
2013-01-01
Renin inhibitors
Grant 8,334,308 - Juteau , et al. December 18, 2
2012-12-18
Renin Inhibitors
App 20120046293 - BAYLY; CHRISTOPHER I. ;   et al.
2012-02-23
Renin inhibitors
Grant 8,076,359 - Dube , et al. December 13, 2
2011-12-13
Renin inhibitors
Grant 8,063,105 - Bayly , et al. November 22, 2
2011-11-22
Renin Inhibitors
App 20110263658 - Juteau; Helene ;   et al.
2011-10-27
Renin Inhibitors
App 20110237622 - Chen; Austin Chih-Yu ;   et al.
2011-09-29
Renin Inhibitors
App 20110207783 - Dube; Daniel ;   et al.
2011-08-25
Secondary amines as renin inhibitors
Grant 7,968,720 - Bezencon , et al. June 28, 2
2011-06-28
3,4-substituted Piperidine Derivatives As Renin Inhibitors
App 20110152316 - Chen; Austin Chih-Yu ;   et al.
2011-06-23
3,4-substituted Piperidine Derivatives As Renin Inhibitors
App 20110053940 - Chen; Austin Chih-Yu ;   et al.
2011-03-03
Novel Piperidine Carboxylic Acid Amine Derivatives
App 20100324052 - Bezencon; Olivier ;   et al.
2010-12-23
Renin Inhibitors
App 20100249163 - Dube; Daniel ;   et al.
2010-09-30
Piperidine carboxylic acid amide derivatives
Grant 7,799,805 - Bezencon , et al. September 21, 2
2010-09-21
Novel Case Of Renin Inhibitors
App 20100120859 - Wu; Tom Yao-Hsiang ;   et al.
2010-05-13
Renin Inhibitors
App 20100063091 - Dube; Daniel ;   et al.
2010-03-11
Renin Inhibitors
App 20090281103 - Bayly; Christopher I. ;   et al.
2009-11-12
Secondary Amines as Renin Inhibitors
App 20090176823 - Bezencon; Olivier ;   et al.
2009-07-09
8-(3-Biaryl)phenylquinoline phosphodiesterase-4 inhibitors
Grant 7,482,456 - Dube , et al. January 27, 2
2009-01-27
Novel Piperidine Carboxylic Acid Amide Derivatives
App 20080214598 - Bezencon; Olivier ;   et al.
2008-09-04
Quinolinones as prostaglandin receptor ligands
Grant 7,348,433 - Dube , et al. March 25, 2
2008-03-25
4-Oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitor and a method of preparing same
App 20080070940 - Dube; Daniel ;   et al.
2008-03-20
4-Oxo-1-3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors
Grant 7,342,024 - Dube , et al. March 11, 2
2008-03-11
4-oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors
Grant 7,238,706 - Dube , et al. July 3, 2
2007-07-03
4-oxo-1-(3-substituted phenyl)-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitor and a method of preparing same
App 20070099951 - Dube; Daniel ;   et al.
2007-05-03
8-(biaryl)quinoline PDE4 inhibitors
Grant 7,153,968 - Dube , et al. December 26, 2
2006-12-26
Hetero-bridge substituted 8-arylquinoline pde4 inhibitors
Grant 7,144,896 - Gallant , et al. December 5, 2
2006-12-05
8-(3-Biaryl)phenylquinoline phosphodiesterase-4 inhibitors
App 20060223850 - Dube; Daniel ;   et al.
2006-10-05
Substituted pyridines as selective cyclooxygenase-2 inhibitors
Grant 7,060,715 - Dube , et al. June 13, 2
2006-06-13
4-Oxo-1-3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors
App 20060058316 - Dube; Daniel ;   et al.
2006-03-16
Use of phosphodiesterase-4 inhibitors as enhancers of cognition
App 20060040981 - Dube; Daniel ;   et al.
2006-02-23
Hetero-bridge substituted 8-arylquinoline pde4 inhibitors
App 20050245513 - Gallant, Michel ;   et al.
2005-11-03
8-(Biaryl)quinoline pde4 inhibitors
App 20050234238 - Dube, Daniel ;   et al.
2005-10-20
Quinolinones as prostaglandin receptor ligands
App 20050222194 - Dube, Daniel ;   et al.
2005-10-06
Substituted 8-arylquinolune PDE4 inhibitors
Grant 6,919,353 - Dube , et al. July 19, 2
2005-07-19
4-Oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors
App 20050107402 - Dube, Daniel ;   et al.
2005-05-19
Substituted pyridines as selective cyclooxygenase-2 inhibitors
App 20050009875 - Dube, Daniel ;   et al.
2005-01-13
Substituted pyridines as selective cyclooxygenase-2 inhibitors
Grant 6,812,346 - Dube , et al. November 2, 2
2004-11-02
Substituted 8-arylquinolune pde4 inhibitors
App 20040162314 - Dube, Daniel ;   et al.
2004-08-19
Substituted pyridines as selective cyclooxygenase-2 inhibitors
App 20040029921 - Dube, Daniel ;   et al.
2004-02-12
Substituted pyridines as selective cyclooxygenase-2 inhibitors
Grant 6,596,736 - Dube , et al. July 22, 2
2003-07-22
Substituted pyridines as selective cyclooxygenase-2 inhibitors
App 20030065011 - Dube, Daniel ;   et al.
2003-04-03
Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
App 20020103226 - Deschenes, Denis ;   et al.
2002-08-01
PDE IV inhibiting compounds, compositions and methods of treatment
Grant 6,204,275 - Friesen , et al. March 20, 2
2001-03-20
2,3,5-trisubstituted pyridines as inhibitors of cyclooxygenase-2
Grant 6,046,217 - Friesen , et al. April 4, 2
2000-04-04
Substituted pyridines as selective cyclooxygenase-2 inhibitors
Grant 6,001,843 - Dube , et al. December 14, 1
1999-12-14
Substituted pyridines as selective cyclooxygenase-2 inhibitors
Grant 5,861,419 - Dube , et al. January 19, 1
1999-01-19
Bisaryl cyclobutenes derivatives as cyclooxygenase inhibitors
Grant 5,817,700 - Dube , et al. October 6, 1
1998-10-06
Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis
Grant 5,308,852 - Girard , et al. May 3, 1
1994-05-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed